Publications by authors named "Tilo Andus"

Claim this Profile
[
[Use of specific antidotes in DOAC-associated severe gastrointestinal bleeding - an expert consensus - Antagonozation of direct oral anticoagulants in gastrointestinal hemorrhages].
Valentin Fuhrmann, Jürgen Koscielny, Thomas Vasilakis, Tilo Andus, Adam Herber

Z Gastroenterol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, Jann Arends, Dirk Arnold

Z Gastroenterol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.
Maria Shipkova, Jutta Franz, Manabu Abe, Corinne Klett, Eberhard Wieland, Tilo Andus

Ther Drug Monit· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Tilo Andus, Andreas Kocjan, Moritz Müser, Andrey Baranovsky, Tatyana L Mikhailova

Inflamm Bowel Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESPEN guidelines on enteral nutrition: liver disease - tube feeding (TF) in patients with esophageal varices is not proven to be safe.
Tilo Andus

Clin Nutr· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased insulin resistance and beta cell activity in patients with Crohn's disease.
Nicole Bregenzer, Alexander Hartmann, Ulrike Strauch, Jürgen Schölmerich, Tilo Andus

Inflamm Bowel Dis· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial.
Eugen Musch, Tilo Andus, Wolfgang Kruis, Andreas Raedler, Martina Spehlmann

Clin Gastroenterol Hepatol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort.
Eike Zankel, Gerhard Rogler, Tilo Andus, Carl-Michael Reng, Jürgen Schölmerich

Eur J Gastroenterol Hepatol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
Angela Hammond, Tilo Andus, Michael Gierend, Karl-Walter Ecker, Jurgen Scholmerich

Hepatogastroenterology· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspiration of a capsule endoscope.
Ingolf Sinn, Bernhard Neef, Tilo Andus

Gastrointest Endosc· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.
Stephan Kiessling, Gerhard Muller-Newen, Sandra N Leeb, Martin Hausmann, Heiko C Rath, Tilo Andus

J Biol Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Suspected cases of severe side effects after infliximab (Remicade) in Germany].
Tilo Andus, Eduard F Stange, Dieter Höffler, Brigitte Keller-Stanislawski

Med Klin (Munich)· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image of the month: "hide-bound" bowel sign in scleroderma.
Bernhard Neef, Hermann Kirsch, Tilo Andus

Gastroenterology· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials.
Silvia Mascheretti, Jochen Hampe, Peter J P Croucher, Susanna Nikolaus, Tilo Andus

Pharmacogenetics· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease.
Hans Herfarth, Florian Obermeier, Tilo Andus, Gerhard Rogler, Susanna Nikolaus

Am J Gastroenterol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for osteoporosis in patients with inflammatory bowel disease by using urinary N-telopeptides.
Nicole Bregenzer, Peter Erban, Helga Albrich, Gerd Schmitz, Stefan Feuerbach, Tilo Andus

Eur J Gastroenterol Hepatol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Cornelia M Gelbmann, Gerhard Rogler, Volker Gross, Michael Gierend, Nicole Bregenzer, Tilo Andus

Am J Gastroenterol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?
Rainer H Straub, Hans Herfarth, Werner Falk, Tilo Andus, Jürgen Schölmerich

J Neuroimmunol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis